Comparison of likert and PI-RADS v2 scoring in the diagnosis of prostate cancer

dc.contributor.authorInan, Ibrahim
dc.contributor.authorAktan, Ahmet
dc.contributor.authorOzkanli, Sidika Seyma
dc.contributor.authorYildirim, Asif
dc.contributor.authorAslan, Ahmet
dc.contributor.authorSenturk Gucel, Senem
dc.contributor.authorErturk, Sukru Mehmet
dc.date.accessioned2022-02-22T14:15:27Z
dc.date.available2022-02-22T14:15:27Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: We aimed to compare the inter- and intra-observer variability and diagnostic performance of PI-RADS v2 and Likert scoring in the evaluation of prostate cancer on multiparametric prostate MR imaging. Material and Methods: MRI findings of 53 patients who had histopathologic diagnosis of prostate cancer and 51 patients who had one or more negative transrectal ultrasound guided prostate biopsy were evaluated retrospectively. The images were assessed by three independent observers blinded to histopathologic results of the patients. Intra-observer and inter-observer variability were evaluated by Cohen’s Kappa coefficient for all possible pairs of observers. ROC curve analysis was used to determine AUC to evaluate diagnostic performance of Likert and PI-RADS v2 scoring with a 1.5T MR in the diagnosis of prostate cancer. Results: Kappa values for 4 or higher PI-RADS v2 scores were calculated and κ=0.59-0.71 for intra-observer and κ=0.48-0.67 for inter-observer variability were obtained. κ=0.54-0.69 for intra-observer and κ=0.42-0.75 for inter-observer reliability were obtained for 4 or higher Likert scoring. AUC was 72% for PI-RADS v2 scores and was 75.9% for Likert scores for determining Gleason 6 or higher prostate cancers. There was not a statistically significant difference in the comparison of Likert and PI-RADS v2 ROC curves. Conclusion: PI-RADS v2 has no significant superiority compared to Likert scoring in intra-observer and inter-observer reliability. Likert and PI-RADS v2 scoring has no difference in the terms of diagnostic capability of prostate cancers.en_US
dc.identifier.citationInan, I., Aktan, A., Seyma Ozkanli, S., Yildirim, A., Aslan, A., Senturk Gucel, S., & Mehmet Erturk, S. (2021). Comparison of likert and PI-RADS v2 scoring in the diagnosis of prostate cancer . Annals of Medical Research,en_US
dc.identifier.doi10.5455/annalsmedres.2018.08.157 2018;25(4)651-5en_US
dc.identifier.urihttps://hdl.handle.net/11616/53856
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleComparison of likert and PI-RADS v2 scoring in the diagnosis of prostate canceren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
651-655.pdf
Boyut:
500.09 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: